Moleculin CEO discusses Annamycin MIRACLE trial progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall St set for lower open as oil prices jump, earnings in focus
- Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 5.76 +5.50 (2,115.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.26 | 52 Week High | $9.58 | |||
| Open | $5.74 | 52 Week Low | $2.34 | |||
| Day High | $6.10 | P/E | N/A | |||
| Day Low | $5.24 | EPS | $-0.34 | |||
| Volume | 36,096 | |||||
